RESUMEN
Haemochromatosis is a common recessive disorder characterized by progressive iron overload, which may lead to severe clinical complications. Most patients are homozygous for the C282Y mutation in HFE on 6p (refs 1-5). A locus for juvenile haemochromatosis (HFE2) maps to 1q (ref. 7). Here we report a new locus (HFE3) on 7q22 and show that a homozygous nonsense mutation in the gene encoding transferrin receptor-2 (TFR2) is found in people with haemochromatosis that maps to HFE3.
Asunto(s)
Mapeo Cromosómico , Cromosomas Humanos Par 7/genética , Hemocromatosis/genética , Mutación/genética , Receptores de Transferrina/genética , Animales , Codón sin Sentido/genética , Femenino , Humanos , Masculino , Ratones , LinajeRESUMEN
Transfusion-induced iron overload is a frequent problem that clinicians have to face in the treatment of patients affected by both myelodysplastic syndrome (MDS) and primary myelofibrosis (PMF). Different options are currently available for chelation therapy, e.g. oral once-daily administration of the iron chelator deferasirox. In 3 patients with MDS and 1 patient with PMF, deferasirox therapy resulted in an improvement in the hemoglobin level and a reduction in transfusion dependence. Our data open new insights regarding the benefit of iron chelation therapy not only for transfusional iron overload of myelodysplastic and myelofibrotic patients but also for the increase in hemoglobin levels. The biological mechanism of action of deferasirox, an effect which is not shared by other iron chelators, is still obscure and requires further investigations.
Asunto(s)
Benzoatos/administración & dosificación , Transfusión Sanguínea , Hemoglobinas/análisis , Síndromes Mielodisplásicos/terapia , Mielofibrosis Primaria/terapia , Triazoles/administración & dosificación , Anciano , Deferasirox , Femenino , Hemoglobinas/efectos de los fármacos , Humanos , Quelantes del Hierro/uso terapéutico , Sobrecarga de Hierro/etiología , Masculino , Síndromes Mielodisplásicos/complicaciones , Mielofibrosis Primaria/complicaciones , Resultado del TratamientoAsunto(s)
Pruebas Genéticas , Antígenos HLA/genética , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Intrones/genética , Proteínas de la Membrana , Mutación/genética , Polimorfismo Genético/genética , Alelos , Sustitución de Aminoácidos/genética , Cartilla de ADN/genética , Frecuencia de los Genes , Genotipo , Hemocromatosis/diagnóstico , Proteína de la Hemocromatosis , Humanos , Reproducibilidad de los ResultadosRESUMEN
Type 3 haemochromatosis (HFE3) is a rare genetic iron overload disease which ultimately lead to compromised organs functioning. HFE3 is caused by mutations in transferrin receptor 2 (TFR2) gene that codes for two main isoforms (Tfr2α and Tfr2ß). Tfr2α is one of the hepatic regulators of iron inhibitor hepcidin. Tfr2ß is an intracellular isoform of the protein involved in the regulation of iron levels in reticuloendothelial cells. It has been recently demonstrated that Tfr2 is also involved in erythropoiesis. This study aims to further investigate Tfr2 erythropoietic role by evaluating the erythropoiesis of two Tfr2 murine models wherein either one or both of Tfr2 isoforms have been selectively silenced (Tfr2 KI and Tfr2 KO). The evaluations were performed in bone marrow and spleen, in 14 days' and 10 weeks' old mice, to assess erythropoiesis in young versus adult animals. The lack of Tfr2α leads to macrocytosis with low reticulocyte number and increased hemoglobin values, together with an anticipation of adult BM erythropoiesis and an increased splenic erythropoiesis. On the other hand, lack of Tfr2ß (Tfr2 KI mice) causes an increased and immature splenic erythropoiesis. Taken together, these data confirm the role of Tfr2α in modulation of erythropoiesis and of Tfr2ß in favoring iron availability for erythropoiesis.
Asunto(s)
Hemocromatosis/genética , Hierro/metabolismo , Isoformas de Proteínas/genética , Receptores de Transferrina/deficiencia , Animales , Modelos Animales de Enfermedad , Eritropoyesis/genética , Hemocromatosis/patología , Hígado/metabolismo , Hígado/patología , Ratones , Ratones Noqueados , Sistema Mononuclear Fagocítico/metabolismo , Sistema Mononuclear Fagocítico/patología , Receptores de Transferrina/genética , Bazo/metabolismo , Bazo/patologíaRESUMEN
Juvenile Hemochromatosis (JH) is a rare genetic disorder that causes iron overload. JH clinical features are similar to those of hemochromatosis (HFE), but the clinical course is more severe and is characterized by an earlier onset and by a prevalence of cardiac symptoms and endocrine dysfunctions. Here we describe seven Italian patients belonging to five unrelated families with clinical features typical of JH. In four out of five families the parents were consanguineous. Analysis of HFE gene mutations in all the cases and nucleotide sequence of the gene in one case excluded this gene as responsible for JH. Segregation analysis of 6p markers closely associated with HFE in families with consanguineous parents clearly showed that JH is unlinked to 6p and thus genetically distinct from HFE.
Asunto(s)
Hemocromatosis/genética , Adolescente , Adulto , Distribución por Edad , Niño , Cromosomas Humanos Par 6/genética , Consanguinidad , Femenino , Ligamiento Genético , Haplotipos/genética , Humanos , Sobrecarga de Hierro/patología , Italia , Escala de Lod , Masculino , LinajeRESUMEN
A transcription map was generated of a 1 Mb interval including the HFE gene on 6p22. Thirty-seven unique cDNA fragments were characterised following their retrieval from hybridisation of immobilised YACs to primary pools of cDNAs prepared from RNA of foetal brain, human liver, foetal human liver, placenta, and CaCo2 cell line. All cDNA fragments were positioned on the physical map on the basis of presence in aligned and overlapping YACs and cosmid clones of the region. The isolated cDNAs together with established or published sequence tagged sites (STSs) and markers provided sufficient landmark density to cover approximately 90% of the 1 Mb interval with cosmid clones. The precise localisation of two known genes (NPT1 and RING finger protein) was established. A minimum of 14 additional transcription units has also been integrated. Twenty-eight cDNA fragments showed no similarity with known sequences, but 20 of these detected discrete mRNAs upon northern analysis. Their characterisation is still under investigation. Eleven new polymorphisms were also identified and localised, and the HFE genomic structure was better defined. This integrated transcription map considerably extends a recently published map of the HFE region. It will be useful for the identification of genetic defects mapping to this region and for providing template resources for genomic sequencing.
Asunto(s)
Cromosomas Humanos Par 6 , Antígenos HLA/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana , Transcripción Genética , Células CACO-2 , Cromosomas Artificiales de Levadura , Cósmidos , ADN Complementario , Genes MHC Clase I , Hemocromatosis/genética , Proteína de la Hemocromatosis , Humanos , Complejo Mayor de Histocompatibilidad , Hibridación de Ácido Nucleico , Mapeo Físico de Cromosoma , Polimorfismo Genético , ARN/genética , Lugares Marcados de SecuenciaAsunto(s)
Apoferritinas/genética , Catarata/genética , Ferritinas/sangre , Mutación Puntual , Secuencia de Bases , Sitios de Unión/genética , ADN/química , ADN/genética , Análisis Mutacional de ADN , Femenino , Genes Dominantes , Humanos , Proteínas Reguladoras del Hierro/genética , Italia , Masculino , Conformación de Ácido Nucleico , Linaje , Regiones Promotoras Genéticas , SíndromeRESUMEN
Hereditary hemochromatosis (HH) is a disorder of iron metabolism that leads to iron overload in middle age and can be caused by homozygosity for the C282Y mutation in the HFE gene. Preliminary studies have estimated the frequency of this mutation at 0.5-1% in Italy, but this has not been verified on a large sample. We analyzed 1,331 Italian newborns for the C282Y mutation in the HFE gene using dried blood spots (DBS) from the Neonatal Screening Center in Turin, Italy. The mutation was assessed using a semi-automatable 5'-nuclease assay (TaqMan technology). We detected 55 heterozygotes and no homozygotes in our sampling, resulting in an overall frequency of 2.1% +/- 0.6 for the C282Y allele. Differences in allele frequency were observed, and ranged from 2.7% +/- 1.3 in samples from Northern Italy, to 1.7% +/- 0.9 in samples from Central-Southern Italy. The low frequency of the at-risk genotype for iron overload suggests that genetic screening for HFE in Italy would not be cost effective. The present study, in addition to defining C282Y frequency, documents detection of the major HFE mutation on routine DBS samples from neonatal screening programs using a semi-automatable, rapid, reliable, and relatively inexpensive approach.
Asunto(s)
Hemocromatosis/diagnóstico , Proteínas de la Membrana , Tamizaje Neonatal/métodos , Reacción en Cadena de la Polimerasa/métodos , Secuencia de Bases , Cartilla de ADN , Tamización de Portadores Genéticos , Antígenos HLA/genética , Hemocromatosis/genética , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Homocigoto , Humanos , Recién Nacido , Italia , Mutación , Proyectos PilotoRESUMEN
Hemojuvelin (HJV) is a recently discovered gene responsible for 1q-linked juvenile hemochromatosis. The majority of mutations characterized in this gene are rare and private, except G320V, identified in patients from different countries. Here, we report the clinical features and the molecular study of a young Irish patient presenting with severe cardiac disease related to iron overload. We sequenced the coding region and the exon-intron boundaries of genes associated with juvenile hemochromatosis, HAMP and HJV encoding hepcidin and hemojuvelin respectively. Two heterozygous HJV mutations were identified: the G320V mutation and the new Q116X mutation that cause a premature stop codon in the protein. This finding increases the number of mutations identified in HJV gene and underlines that the G320V is a recurrent mutation, even in Northern Europe.
Asunto(s)
Hemocromatosis/genética , Proteínas de la Membrana/genética , Mutación Missense , Adolescente , Sustitución de Aminoácidos , Codón sin Sentido , Femenino , Proteínas Ligadas a GPI , Cardiopatías/etiología , Hemocromatosis/etiología , Proteína de la Hemocromatosis , Heterocigoto , Humanos , Irlanda , Sobrecarga de Hierro/complicacionesRESUMEN
Microcytosis is a common hematological finding, usually related to iron deficiency or beta-thalassemia. When both of these conditions are excluded, alpha-thalassemia must be considered in the differential diagnosis. No simple biochemical test is able to diagnose the alpha-thalassemia trait. Using PCR amplification of the breakpoint in deletional forms, and amplification of the alpha 2 gene and restriction enzyme digestion in non-deletional forms, we identified the alpha-thalassemia carrier status in 42 out of 51 (82%) patients with microcytosis or slight microcytic anemia, unrelated to iron deficiency or beta-thalassemia. Our results underline the usefulness of molecular tests in clinical practice.
Asunto(s)
Anemia Ferropénica/diagnóstico , Talasemia alfa/diagnóstico , Anemia Ferropénica/complicaciones , Anemia Ferropénica/genética , Femenino , Genotipo , Humanos , Masculino , Reacción en Cadena de la Polimerasa , Talasemia alfa/complicaciones , Talasemia alfa/genéticaRESUMEN
We describe a complex polymorphic repeat discovered analyzing YAC 225B1, which spans the region between the HLA-A and HLA-E loci. The repeat consists of a variable number of the nucleotide A followed by a variable number of the trinucleotide AAG [(A)n(AAG)n]. Three different alleles were detected with an observed heterozygosity of 0.30.
Asunto(s)
Genes MHC Clase I/genética , Polimorfismo Genético , Secuencias Repetitivas de Ácidos Nucleicos , Alelos , Secuencia de Bases , Antígenos HLA/genética , Antígenos HLA-A/genética , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Datos de Secuencia Molecular , Oligodesoxirribonucleótidos , Antígenos HLA-ERESUMEN
Hereditary hemochromatosis (HH) is a genetically heterogeneous disease. The HFE gene resides on chromosome 6 and its mutations account for the majority of HH cases in populations of northern European ancestry. Recently, two new types of hemochromatosis have been identified: Juvenile hemochromatosis (JH or HFE2), which maps to chromosome 1q21, and an adult form defined as HFE 3, which results from mutations of the TFR 2 gene, located at 7q22. We have performed a linkage study in five unrelated families of Greek origin with non-HFE hemochromatosis. Linkage at the chromosome 1q21 JH locus was detected in affected members with the use of polymorphic markers. Comparison of haplotypes between Greek and Italian JH patients revealed the presence of a common haplotype. However, the fact that many other haplotypes carrying the JH defect were observed in the two populations indicates that the respective mutations may have occurred in different genetic backgrounds. We suggest that hemochromatosis patients without HFE mutations should be evaluated for other possible types of hemochromatosis since hemochromatosis type 3 (HFE3) has a clinical appearance similar to HFE 1, and JH may have a late onset in some cases.
Asunto(s)
Cromosomas Humanos Par 1/genética , Hemocromatosis/genética , Proteínas de la Membrana , Adulto , Edad de Inicio , Niño , Mapeo Cromosómico , Cromosomas Artificiales de Levadura/genética , Cromosomas Humanos Par 1/ultraestructura , Cromosomas Humanos Par 6/genética , Consanguinidad , Etnicidad/genética , Femenino , Efecto Fundador , Ligamiento Genético , Grecia/epidemiología , Antígenos HLA/genética , Haplotipos/genética , Hemocromatosis/epidemiología , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Italia/etnología , Masculino , Linaje , Reacción en Cadena de la PolimerasaRESUMEN
Hemochromatosis (HC) is an inherited disorder of iron metabolism and is frequently seen in Caucasians. The biochemical defect and the responsible gene are unknown, but the HC locus is closely linked to HLA-A on human chromosome 6 in the region 6p21.3. Although extensive studies have been performed in several populations, the precise location of the gene is still undefined. Linkage disequilibrium with HC has been detected for loci that are 3 cM apart: HLA class I and D6S105, which is located on the telomeric side of HLA-A. We have analyzed the inheritance of several multi-allele polymorphisms that map to 6p (D6S265, Y52, HLA-F, D6S306, D6S105, D6S464, D6S299) in 34 Italian HC families and in 17 unrelated patients. Significant association with HC was shown for alleles of multiple markers in the HLA-A region, for the distant marker D6S105, but not for the D6S299 marker at 4 cM from HLA-A on the telomeric side. HC status was unambiguously assigned to 70 affected and 63 unaffected chromosomes from family studies. Thirty five different haplotypes were found in 70 HC chromosomes when considering four markers most tightly associated with the disease. A predominant haplotype comprising alleles 1-3-1-8 (marker order D6S265, HLA-A, Y52, D6S105) accounted for 30% of the HC chromosomes and was absent in normals. A minority of other HC haplotypes could be related to the major haplotype by assuming single crossover events. Results of haplotype studies suggest a founder effect in the Italian population, as previously shown in Australian patients, and a possible common mutation shared with affected individuals of Celtic origin.
Asunto(s)
Cromosomas Humanos Par 6/genética , ADN Satélite/genética , Hemocromatosis/genética , Repeticiones de Microsatélite/genética , Alelos , Ligamiento Genético , Humanos , ItaliaRESUMEN
Hereditary hyperferritinaemia-cataract syndrome is an autosomal dominant disorder characterized by a constitutively increased synthesis of L-ferritin in the absence of iron overload. The disorder is associated with point mutations in the iron-responsive element (IRE) of L-ferritin mRNA. We report a new mutation, G51C, identified in two members of a Canadian family, presenting a moderate increase in serum ferritin and a clinically silent bilateral cataract. Gel retardation assays showed that the binding of the mutated IRE to iron-regulatory proteins (IRPs) was reduced compared with the wild type. Structural modelling predicted that the G51C induces a rearrangement of base pairing at the lateral bulge of the IRE structure which is likely to modify IRE conformation.
Asunto(s)
Anemia/genética , Catarata/genética , Ferritinas/sangre , Proteínas Hierro-Azufre/genética , Mutación Puntual , Proteínas de Unión al ARN/genética , Adolescente , Adulto , Anemia/sangre , Catarata/sangre , Electroforesis en Gel de Poliacrilamida , Femenino , Humanos , Proteínas Reguladoras del Hierro , Masculino , Persona de Mediana Edad , ARN Mensajero/genética , Análisis de Secuencia de ADN , SíndromeRESUMEN
Allele and genotype frequencies of five microsatellites on the short arm of chromosome 6 have been determined in 158 subjects from 14 large Italian families, using polymerase chain reaction amplification and a non-radioactive method of detection. The markers studied were: D6S89, D6S109, D6S105, pLR12 and HLA-F; their heterozygosity ranged from 0.65 to 0.78. Two point and three point linkage analysis among these markers and HLA-A serological types--available for all the studied samples--allowed construction of a partial genetic map telomeric to HLA-A. Our results may be useful for linkage analysis of genetic disorders mapping on this region of 6p.
Asunto(s)
Mapeo Cromosómico , Cromosomas Humanos Par 6 , ADN Satélite/genética , Antígenos HLA-A/genética , Secuencias Repetitivas de Ácidos Nucleicos , Alelos , Secuencia de Bases , Cartilla de ADN , Femenino , Marcadores Genéticos , Humanos , Italia , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Recombinación Genética , TelómeroRESUMEN
Hemochromatosis type 2 (HFE2) or juvenile hemochromatosis (JH) is a rare recessive disorder that causes iron overload, characterized by early onset and severe clinical course. The JH locus maps to chromosome 1q, in a 4-cM region encompassing markers D1S442 and D1S2347. Recently a gene named ZIRTL has been characterized and mapped to 1q21. This gene belongs to a family of divalent metal ion-transporting genes that encode for proteins involved in transport of different metals, including iron. Thus, the ZIRTL gene represents a positional and functional candidate for JH. Here we further restrict the candidate region through segregation analysis of two new polymorphic markers and haplotype analysis in JH families. Furthermore, we exclude ZIRTL as a JH candidate gene showing that it maps outside the critical interval and that its genomic sequence is normal in three patients.
Asunto(s)
Proteínas Portadoras/genética , Proteínas de Transporte de Catión , Cromosomas Humanos Par 1 , Hemocromatosis/genética , Cromosomas Artificiales de Levadura , Mapeo Contig , Femenino , Marcadores Genéticos , Humanos , Italia , Masculino , Núcleo Familiar , LinajeRESUMEN
BACKGROUND: Thalassemia intermedia patients usually do not require blood transfusions; however, all show variable degrees of erythropoietic marrow expansion to compensate for more or less marked anemia, and this represents the major cause of complications in untransfused individuals. MATERIALS AND METHODS: To assess the degree of erythropoietic expansion in thalassemia intermedia, serum erythropoietin (sEpo) and serum transferrin receptor (sTfr) were determined in thirty Italian patient's characterized by their beta-globin genotype. RESULTS: Six patients showed inappropriately low sEpo levels (O/P ratio < 0.85). Even excluding these cases, no clear relationship was observed between Hb levels and sEpo or sTfr. Two groups of patients were compared: the first with low HbF (< 40%) that included the majority of beta(+) genotypes, and the second with high HbF (> 40%) that contained a prevalence of beta(0) genotypes. Hb levels were similar in the two groups: 8.09 +/- 1.15 g/dL in low HbF and 8.82 +/- 1.28 g/dL in high HbF patients. Mean sEpo was 112 +/- 78.02 mU/mL (O/P ratio = 0.98 +/- 0.22) in the first and 246.62 +/- 184.30 mU/mL (O/P ratio = 1.25 +/- 0.30) in the second group, with a statistically significant difference, as expected, because of HbF oxygen hyperaffinity. No significant difference in sTfr levels was observed, indicating a comparable erythropoietic response in the two groups. CONCLUSIONS: The relationships between anemia, HbF and total erythropoiesis in thalassemia are more complex than expected. Further studies of subjects with high HbF and benign conditions, such as HPFH, could be of help in clarifying this point, to the aim of safely increasing HbF in thalassemia intermedia.
Asunto(s)
Eritropoyetina/genética , Receptores de Transferrina/genética , Talasemia beta/genética , Adulto , Eritropoyetina/sangre , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Receptores de Transferrina/sangre , Talasemia beta/sangreRESUMEN
GABA (gamma-amino-butyric acid) receptors are a family of proteins involved in the GABAergic neurotransmission of the mammalian central nervous system (CNS). They have physiological importance and clinical relevance in several diseases. We report the identification, cloning, and fine mapping of the human cDNA for GABAB receptor. A 4.2-Kb cDNA containing an open reading frame for a predicted protein of 960 aa was isolated from a fetal brain cDNA library. It had a strong identity (91.5%) with the rat GABAB receptor (rGB1A) nucleotide sequence, that corresponded to 98.6% identity at the amino acid level. Expression of the GABAB at the transcription level was detected by Northern analysis in all brain areas examined. The GABAB receptor has been mapped to human chromosome 6p21.3 within the HLA class I region close to the HLA-F gene. Susceptibility loci for multiple sclerosis, epilepsy, and schizophrenia have been suggested to map in this region.
Asunto(s)
Mapeo Cromosómico , ADN Complementario/genética , Receptores de GABA-B/genética , Ácido gamma-Aminobutírico/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , ADN Complementario/análisis , Humanos , Datos de Secuencia Molecular , Ratas , Receptores de GABA-B/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADN , Transducción de SeñalRESUMEN
Hemochromatosis (HH) is usually caused by the homozygous state for C282Y mutation in the HFE gene. A minority of iron loaded patients have no mutations in this gene. An infrequent subset shows an early-onset aggressive disorder, denoted juvenile hemochromatosis (JH), which has no linkage to 6p. In this report we describe six patients from three unrelated Italian families, four men and two women, aged 21 to 44 with the typical hemochromatosis phenotype, who are homozygous for the wild type allele at the HFE gene. In two families the disorder is unlinked to 6p; in one family some features of the juvenile form are seen, but linkage to 6p is not excluded. Our results point to genetic forms of hemochromatosis not associated with HFE and raise the problem of whether non-HFE hemochromatosis in Italy is related to the "juvenile" form. They also emphasize the importance of phenotypic as well as genetic diagnosis of HH.